
Regional Monitoring EECA
by ECUO PLWH

# | Country | Source of financing | Manufacturer | Tradename | INN | Form | Price per unit ($) | Units in purchase | Units in package | Price per package ($) | Packages in purchase | Price per purchase ($) | Distributor | Year | Purchase date | Delivery date | Registered | In the list of main (vital) medications | WHO prequalification |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Republic of Armenia | Global Fund | Emcure Pharmaceuticals Ltd. | Atazanavir+Ritonavir - FDC | 300mg+100mg tab | 0.55 | 3870 | 30 | 16.5 | 129 | 2128.5 | partnership for supply. chain management (PFSCM) | 2016 | No | Yes | Not specified | |||
2 | Georgia | Global Fund | MYLAN LABORATORIES LTD | Atazanavir+Ritonavir - FDC | 300mg+100mg tab | 0.55 | 58800 | 30 | 16.5 | 1960 | 32340 | partnership for supply. chain management (PFSCM) | 2016 | Yes | Yes | Not specified | |||
3 | Republic of Tajikistan | Global Fund | Emcure Pharmaceuticals Ltd. | Atazanavir+Ritonavir - FDC | 300mg+100mg tab | 0.55 | 20160 | 30 | 16.5 | 672 | 11088 | UNDP/UNICEF | Not specified | Not specified | Not specified | ||||
4 | Republic of Armenia | Global Fund | Emcure Pharmaceuticals Ltd. | Atazanavir+Ritonavir - FDC | 300mg+100mg tab | 0.55 | 4320 | 30 | 16.5 | 144 | 2376 | partnership for supply. chain management (PFSCM) | 2016 | No | Yes | Not specified | |||
5 | Republiс of Azerbaijan | Government | Cipla Ltd | Atazanavir+Ritonavir - FDC | 300mg+100mg tab | 2.2367 | 5040 | 30 | 67.1 | 168 | 11272.8 | 2015 | Yes | Yes | Not specified |